Y-mAbs Therapeutics, Inc. Operating Lease Liability
Y-mAbs Therapeutics, Inc. had Operating Lease Liability of $3.12 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-08-08
- 2025-06-30: Operating Lease, Liability $3.12M.
- 2025-03-31: Operating Lease, Liability $603.00K.
- 2024-12-31: Operating Lease, Liability $820.00K.
- 2024-09-30: Operating Lease, Liability $1.07M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-06-30 | $3.12M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $603.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $820.00K 10-Q · filed 2025-08-08 |
| 2024-09-30 | $1.07M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.27M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.18M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.42M 10-K · filed 2025-03-04 |
| 2023-09-30 | $1.62M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.25M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.48M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $1.77M 10-K · filed 2024-02-29 |
| 2022-09-30 | $2.22M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $2.39M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $3.05M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $3.63M 10-K · filed 2023-03-30 |
| 2021-09-30 | $2.50M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $3.00M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $3.49M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $3.98M 10-K · filed 2022-03-01 |
| 2020-09-30 | $4.40M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.97M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.09M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.23M 10-K · filed 2021-03-01 |
| 2019-09-30 | $2.34M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $2.48M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.65M 10-Q · filed 2019-05-10 |